864 related articles for article (PubMed ID: 33946479)
1. Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients.
Marín-Corral J; Rodríguez-Morató J; Gomez-Gomez A; Pascual-Guardia S; Muñoz-Bermúdez R; Salazar-Degracia A; Pérez-Terán P; Restrepo MI; Khymenets O; Haro N; Masclans JR; Pozo OJ
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946479
[TBL] [Abstract][Full Text] [Related]
2. Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.
Ansone L; Briviba M; Silamikelis I; Terentjeva A; Perkons I; Birzniece L; Rovite V; Rozentale B; Viksna L; Kolesova O; Klavins K; Klovins J
Microbiol Spectr; 2021 Dec; 9(3):e0033821. PubMed ID: 34878333
[TBL] [Abstract][Full Text] [Related]
3. Metabolic predictors of COVID-19 mortality and severity: a survival analysis.
Abdallah AM; Doudin A; Sulaiman TO; Jamil O; Arif R; Sada FA; Yassine HM; Elrayess MA; Elzouki AN; Emara MM; Thillaiappan NB; Cyprian FS
Front Immunol; 2024; 15():1353903. PubMed ID: 38799469
[TBL] [Abstract][Full Text] [Related]
4. Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection.
D'Amora P; Silva IDCG; Budib MA; Ayache R; Silva RMS; Silva FC; Appel RM; Júnior SS; Pontes HBD; Alvarenga AC; Arima EC; Martins WG; Silva NLF; Diaz RS; Salzgeber MB; Palma AM; Evans SS; Nagourney RA
PLoS One; 2021; 16(12):e0259909. PubMed ID: 34851990
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics study of COVID-19 patients in four different clinical stages.
Valdés A; Moreno LO; Rello SR; Orduña A; Bernardo D; Cifuentes A
Sci Rep; 2022 Jan; 12(1):1650. PubMed ID: 35102215
[TBL] [Abstract][Full Text] [Related]
6. Biological and Clinical Factors Contributing to the Metabolic Heterogeneity of Hospitalized Patients with and without COVID-19.
D'Alessandro A; Thomas T; Akpan IJ; Reisz JA; Cendali FI; Gamboni F; Nemkov T; Thangaraju K; Katneni U; Tanaka K; Kahn S; Wei AZ; Valk JE; Hudson KE; Roh D; Moriconi C; Zimring JC; Hod EA; Spitalnik SL; Buehler PW; Francis RO
Cells; 2021 Sep; 10(9):. PubMed ID: 34571942
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of inflammatory biomarkers and vitamins in hospitalized patients with SARS-CoV-2 infection and post-COVID syndrome.
Krčmová LK; Javorská L; Matoušová K; Šmahel P; Skála M; Kopecký M; Suwanvecho C; Přívratská N; Turoňová D; Melichar B
Clin Chem Lab Med; 2024 May; 62(6):1217-1227. PubMed ID: 38374668
[TBL] [Abstract][Full Text] [Related]
8. Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19.
Dewulf JP; Martin M; Marie S; Oguz F; Belkhir L; De Greef J; Yombi JC; Wittebole X; Laterre PF; Jadoul M; Gatto L; Bommer GT; Morelle J
Sci Rep; 2022 Jun; 12(1):9959. PubMed ID: 35705608
[TBL] [Abstract][Full Text] [Related]
9. The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism.
Caterino M; Costanzo M; Fedele R; Cevenini A; Gelzo M; Di Minno A; Andolfo I; Capasso M; Russo R; Annunziata A; Calabrese C; Fiorentino G; D'Abbraccio M; Dell'Isola C; Fusco FM; Parrella R; Fabbrocini G; Gentile I; Castaldo G; Ruoppolo M
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502454
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status.
Thomas T; Stefanoni D; Reisz JA; Nemkov T; Bertolone L; Francis RO; Hudson KE; Zimring JC; Hansen KC; Hod EA; Spitalnik SL; D'Alessandro A
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32559180
[TBL] [Abstract][Full Text] [Related]
11. Saliva metabolomic profile of COVID-19 patients associates with disease severity.
Saheb Sharif-Askari N; Soares NC; Mohamed HA; Saheb Sharif-Askari F; Alsayed HAH; Al-Hroub H; Salameh L; Osman RS; Mahboub B; Hamid Q; Semreen MH; Halwani R
Metabolomics; 2022 Oct; 18(11):81. PubMed ID: 36271948
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning.
Elgedawy GA; Samir M; Elabd NS; Elsaid HH; Enar M; Salem RH; Montaser BA; AboShabaan HS; Seddik RM; El-Askaeri SM; Omar MM; Helal ML
PLoS One; 2024; 19(5):e0302977. PubMed ID: 38814977
[TBL] [Abstract][Full Text] [Related]
13. Significance of nitrosative stress and glycoxidation products in the diagnosis of COVID-19.
Wolszczak-Biedrzycka B; Dorf J; Matowicka-Karna J; Wojewódzka-Żeleźniakowicz M; Żukowski P; Zalewska A; Maciejczyk M
Sci Rep; 2024 Apr; 14(1):9198. PubMed ID: 38649417
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation.
Ceballos FC; Virseda-Berdices A; Resino S; Ryan P; Martínez-González O; Peréz-García F; Martin-Vicente M; Brochado-Kith O; Blancas R; Bartolome-Sánchez S; Vidal-Alcántara EJ; Albóniga-Díez OE; Cuadros-González J; Blanca-López N; Martínez I; Martinez-Acitores IR; Barbas C; Fernández-Rodríguez A; Jiménez-Sousa MÁ
Front Immunol; 2022; 13():925558. PubMed ID: 35844615
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication.
Krishnan S; Nordqvist H; Ambikan AT; Gupta S; Sperk M; Svensson-Akusjärvi S; Mikaeloff F; Benfeitas R; Saccon E; Ponnan SM; Rodriguez JE; Nikouyan N; Odeh A; Ahlén G; Asghar M; Sällberg M; Vesterbacka J; Nowak P; Végvári Á; Sönnerborg A; Treutiger CJ; Neogi U
Mol Cell Proteomics; 2021; 20():100159. PubMed ID: 34619366
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment.
Rendeiro AF; Vorkas CK; Krumsiek J; Singh HK; Kapadia SN; Cappelli LV; Cacciapuoti MT; Inghirami G; Elemento O; Salvatore M
Front Immunol; 2021; 12():809937. PubMed ID: 35095900
[TBL] [Abstract][Full Text] [Related]
17. Serum neopterin levels in relation to mild and severe COVID-19.
Robertson J; Gostner JM; Nilsson S; Andersson LM; Fuchs D; Gisslen M
BMC Infect Dis; 2020 Dec; 20(1):942. PubMed ID: 33302893
[TBL] [Abstract][Full Text] [Related]
18. Immunometabolic signatures predict risk of progression to sepsis in COVID-19.
Herrera-Van Oostdam AS; Castañeda-Delgado JE; Oropeza-Valdez JJ; Borrego JC; Monárrez-Espino J; Zheng J; Mandal R; Zhang L; Soto-Guzmán E; Fernández-Ruiz JC; Ochoa-González F; Trejo Medinilla FM; López JA; Wishart DS; Enciso-Moreno JA; López-Hernández Y
PLoS One; 2021; 16(8):e0256784. PubMed ID: 34460840
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the lipid profile associate with a dysregulated inflammatory, prothrombotic, anti-fibrinolytic state and development of severe acute kidney injury in coronavirus disease 2019 (COVID-19): A study from Cincinnati, USA.
Henry BM; Szergyuk I; de Oliveira MHS; Abosamak MF; Benoit SW; Benoit JL; Lippi G
Diabetes Metab Syndr; 2021; 15(3):863-868. PubMed ID: 33878674
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity.
Sindelar M; Stancliffe E; Schwaiger-Haber M; Anbukumar DS; Adkins-Travis K; Goss CW; O'Halloran JA; Mudd PA; Liu WC; Albrecht RA; García-Sastre A; Shriver LP; Patti GJ
Cell Rep Med; 2021 Aug; 2(8):100369. PubMed ID: 34308390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
